Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nelotanserin for Visual Hallucinations in Lewy Body Dementia
NCT02640729Phase 2Completed
- Sponsor
- Sio Gene Therapies
- Start
- Dec 2015
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nelotanserin in Lewy body dementia (LBD), Parkinson's disease dementia (PDD), sponsored by Sio Gene Therapies. Started Dec 2015; status: completed.
02
Drugs
nelotanserin
03
Conditions
Lewy body dementia (LBD)Parkinson's disease dementia (PDD)
Beyond the preview
Go deeper on NCT02640729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02640729.